ArticleThe EMBO journal2023

IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

Keisuke Shigeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.